Your browser doesn't support javascript.
loading
Baseline malaria prevalence at the targeted pre-elimination districts in Ethiopia.
Nega, Desalegn; Abera, Adugna; Gidey, Bokretsion; Mekasha, Sindew; Abebe, Abnet; Dillu, Dereje; Mehari, Degu; Assefa, Gudissa; Hailu, Samuel; Haile, Mebrahatom; Etana, Kebede; Solomon, Hiwot; Tesfaye, Gezahagn; Nigatu, Daniel; Destaw, Zelalem; Tesfaye, Berhane; Serda, Belendia; Yeshiwondim, Asnakew; Getachew, Assefaw; Teka, Hiwot; Nahusenay, Honelegn; Abdelmenan, Semira; Reda, Hailemariam; Bekele, Worku; Zewdie, Ayele; Tollera, Getachew; Assefa, Ashenafi; Tasew, Geremew; Woyessa, Adugna; Abate, Ebba.
Afiliação
  • Nega D; Ethiopian Public Health Institute, Addis Ababa, Ethiopia. desalegn24@gmail.com.
  • Abera A; Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
  • Gidey B; Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
  • Mekasha S; Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
  • Abebe A; Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
  • Dillu D; Federal Ministry of Health, Addis Ababa, Ethiopia.
  • Mehari D; Federal Ministry of Health, Addis Ababa, Ethiopia.
  • Assefa G; Federal Ministry of Health, Addis Ababa, Ethiopia.
  • Hailu S; Federal Ministry of Health, Addis Ababa, Ethiopia.
  • Haile M; Federal Ministry of Health, Addis Ababa, Ethiopia.
  • Etana K; Federal Ministry of Health, Addis Ababa, Ethiopia.
  • Solomon H; Federal Ministry of Health, Addis Ababa, Ethiopia.
  • Tesfaye G; Federal Ministry of Health, Addis Ababa, Ethiopia.
  • Nigatu D; Central Statistical Agency, Addis Ababa, Ethiopia.
  • Destaw Z; Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
  • Tesfaye B; Malaria Control and Elimination Partnership in Africa (MACEPA) at PATH, Addis Ababa, Ethiopia.
  • Serda B; Malaria Control and Elimination Partnership in Africa (MACEPA) at PATH, Addis Ababa, Ethiopia.
  • Yeshiwondim A; Malaria Control and Elimination Partnership in Africa (MACEPA) at PATH, Addis Ababa, Ethiopia.
  • Getachew A; Malaria Control and Elimination Partnership in Africa (MACEPA) at PATH, Addis Ababa, Ethiopia.
  • Teka H; President's Malaria Initiative (PMI), Addis Ababa, Ethiopia.
  • Nahusenay H; Addis Continental Institute of Public Health, Addis Ababa, Ethiopia.
  • Abdelmenan S; Addis Continental Institute of Public Health, Addis Ababa, Ethiopia.
  • Reda H; Clinton Health Access Initiative, Inc. (CHAI), Addis Ababa, Ethiopia.
  • Bekele W; World Health Organization (WHO), Addis Ababa, Ethiopia.
  • Zewdie A; Addis Continental Institute of Public Health, Addis Ababa, Ethiopia.
  • Tollera G; Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
  • Assefa A; Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
  • Tasew G; Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
  • Woyessa A; Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
  • Abate E; Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
BMC Public Health ; 21(1): 1996, 2021 11 03.
Article em En | MEDLINE | ID: mdl-34732150
ABSTRACT

BACKGROUND:

Encouraged by the previous success in malaria control and prevention strategies, the Ethiopian ministry of health launched malaria elimination with a stepwise approach by primarily targeting the low-transmission Districts and their adjacent areas/zones in order to shrink the country's malaria map progressively. Hence, this community survey was conducted to establish baseline malaria information at the preliminary phase of elimination at targeted settings.

METHODS:

A community-based cross-sectional survey was conducted at 20 malaria-elimination targeted Districts selected from five Regional states and one city administration in Ethiopia. The GPS-enabled smartphones programmed with Open Data Kit were used to enumerate 9326 study households and collect data from 29,993 residents. CareStart™ Malaria PAN (pLDH) Rapid Diagnostic Tests (RDTs) were used for blood testing at the field level. Armpit digital thermometers were used to measure axillary temperature.

RESULT:

Overall malaria prevalence by RDTs was 1.17% (339/28973). The prevalence at District levels ranged from 0.0 to 4.7%. The proportion of symptomatic cases (axillary temperature > 37.5oc) in the survey was 9.2% (2760/29993). Among the 2510 symptomatic individuals tested with RDTs, only 3.35% (84/2510) were malaria positive. The 75.2% (255/339) of all malaria positives were asymptomatic. Of the total asymptomatic malaria cases, 10.2% (26/255) were under-five children and 89.8% (229/255) were above 5 years of age.

CONCLUSION:

The study shows a decrease in malaria prevalence compared to the reports of previous malaria indicator surveys in the country. The finding can be used as a baseline for measuring the achievement of ongoing malaria elimination efforts. Particularly, the high prevalence of asymptomatic individuals (0.88%) in these transmission settings indicates there may be sustaining hidden transmission. Therefore, active case detection with more sensitive diagnostic techniques is suggested to know more real magnitude of residual malaria in the elimination-targeted areas.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Malária Falciparum / Malária Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Child / Humans País/Região como assunto: Africa Idioma: En Revista: BMC Public Health Assunto da revista: SAUDE PUBLICA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Etiópia

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Malária Falciparum / Malária Tipo de estudo: Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Child / Humans País/Região como assunto: Africa Idioma: En Revista: BMC Public Health Assunto da revista: SAUDE PUBLICA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Etiópia